← All trials
NCT01533480
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2012
- Primary completion
- Dec 1, 2015
- Completion date
- Apr 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 80
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Lifelong Vision FoundationLead sponsor
- Lifelong Vision FoundationOverall official - principal investigator
- Virginia Eye ConsultantsOverall official - principal investigator
- Eye Surgeons of IndianaOverall official - principal investigator
- Brar-Parekh Eye AssociatesOverall official - principal investigator
- University of the PhilippinesOverall official - principal investigator
- Lifelong Vision FoundationStudy director
- Bausch & LombCollaborator
- Chicago Cornea Consultants, LTDOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.